{"id":"amorolfine","rwe":[{"pmid":"41534357","year":"2026","title":"Hexaconazole promotes deoxynivalenol synthesis by interfering with farnesyl pyrophosphate metabolism in Fusarium graminearum.","finding":"","journal":"Ecotoxicology and environmental safety","studyType":"Clinical Study"},{"pmid":"41517574","year":"2026","title":"Fingernail Onychomycosis: A Laboratory-Based Retrospective Study with Species Profiling and Antifungal Susceptibility of Yeasts.","finding":"","journal":"Journal of clinical medicine","studyType":"Clinical Study"},{"pmid":"41250813","year":"2025","title":"The First Isolation of Multiple Antifungal-Drug-Resistant Trichophyton Rubrum in China and the Novel Resistance Mechanism.","finding":"","journal":"Mycoses","studyType":"Clinical Study"},{"pmid":"40936384","year":"2025","title":"Amorolfine hydrochloride cream and 2% crisaborole ointment: a study on their therapeutic benefits for keratotic tinea pedis.","finding":"","journal":"The Journal of dermatological treatment","studyType":"Clinical Study"},{"pmid":"40838978","year":"2025","title":"In vitro susceptibility profile of Brazilian Sporothrix brasiliensis isolates to amorolfine hydrochloride and itraconazole.","finding":"","journal":"Medical mycology","studyType":"Clinical Study"}],"tags":[{"label":"amorolfine","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"D01AE16","category":"atc"},{"label":"Active","category":"status"},{"label":"Anti-Infective Agents","category":"pharmacology"},{"label":"Antifungal Agents","category":"pharmacology"}],"phase":"phase_3","safety":{"safetySignals":[{"llr":74.375,"date":"","count":9,"signal":"Pseudoaldosteronism","source":"DrugCentral FAERS","actionTaken":"Reported 9 times (LLR=74)"}],"commonSideEffects":[{"effect":"Pseudoaldosteronism","drugRate":"LLR 74","severity":"common"}]},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"loceryl","offLabel":[],"synonyms":["amorolfine","loceryl","amorolfine hydrochloride","amorolfine HCl"],"timeline":[],"brandName":"Loceryl","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"amorolfine","explanation":"Imagine your body's cells are like houses, and the fungal cells are like unwanted guests trying to move in. Loceryl helps keep the unwanted guests from building their homes by blocking the materials they need to construct them. This makes it harder for the fungal cells to grow and multiply.","oneSentence":"Loceryl works by inhibiting the growth of fungal cells, specifically by interfering with the synthesis of ergosterol, a critical component of fungal cell membranes.","technicalDetail":"Loceryl exerts its antifungal effects by inhibiting the enzyme lanosterol 14α-demethylase, which is essential for the conversion of lanosterol to ergosterol in fungal cell membranes."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/188","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=AMOROLFINE","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=AMOROLFINE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T08:44:24.616258","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T08:40:54.605679+00:00","fieldsConflicting":0,"overallConfidence":0.95},"biosimilars":[],"competitors":[{"drugName":"undecylenic acid","drugSlug":"undecylenic-acid","fdaApproval":"","relationship":"same-class"},{"drugName":"chlorphenesin carbamate","drugSlug":"chlorphenesin-carbamate","fdaApproval":"1965-06-14","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"haloprogin","drugSlug":"haloprogin","fdaApproval":"","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"selenium sulfide","drugSlug":"selenium-sulfide","fdaApproval":"1951-05-17","genericCount":6,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"ciclopirox","drugSlug":"ciclopirox","fdaApproval":"1982-12-30","genericCount":17,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"terbinafine","drugSlug":"terbinafine","fdaApproval":"1992-12-30","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"tolnaftate","drugSlug":"tolnaftate","fdaApproval":"","relationship":"same-class"},{"drugName":"flucytosine","drugSlug":"flucytosine","fdaApproval":"1971-11-26","genericCount":6,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"naftifine","drugSlug":"naftifine","fdaApproval":"1988-02-29","patentExpiry":"Jan 31, 2033","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"butenafine","drugSlug":"butenafine","fdaApproval":"1996-10-18","genericCount":1,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"tavaborole","drugSlug":"tavaborole","fdaApproval":"2014-07-07","genericCount":9,"patentStatus":"Off-patent — generic available","relationship":"same-class"}],"genericName":"amorolfine","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"undecylenic-acid","brandName":"undecylenic acid","genericName":"undecylenic acid","approvalYear":"","relationship":"same-class"},{"drugId":"chlorphenesin-carbamate","brandName":"chlorphenesin carbamate","genericName":"chlorphenesin carbamate","approvalYear":"1965","relationship":"same-class"},{"drugId":"haloprogin","brandName":"haloprogin","genericName":"haloprogin","approvalYear":"","relationship":"same-class"},{"drugId":"selenium-sulfide","brandName":"selenium sulfide","genericName":"selenium sulfide","approvalYear":"1951","relationship":"same-class"},{"drugId":"ciclopirox","brandName":"ciclopirox","genericName":"ciclopirox","approvalYear":"1982","relationship":"same-class"},{"drugId":"terbinafine","brandName":"terbinafine","genericName":"terbinafine","approvalYear":"1992","relationship":"same-class"},{"drugId":"tolnaftate","brandName":"tolnaftate","genericName":"tolnaftate","approvalYear":"","relationship":"same-class"},{"drugId":"flucytosine","brandName":"flucytosine","genericName":"flucytosine","approvalYear":"1971","relationship":"same-class"},{"drugId":"naftifine","brandName":"naftifine","genericName":"naftifine","approvalYear":"1988","relationship":"same-class"},{"drugId":"butenafine","brandName":"butenafine","genericName":"butenafine","approvalYear":"1996","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT05482763","phase":"","title":"Mycosis Culture Collection From Dermatological Isolated","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Rome Tor Vergata","startDate":"2022-07-20","conditions":["Onychomycosis","Resistant Infection","Nail Diseases"],"enrollment":200,"completionDate":"2025-12-25"},{"nctId":"NCT06254027","phase":"NA","title":"Clinical Investigation for the Evaluation of Efficacy and Safety of Two Medical Devices for Onychomycosis Treatment","status":"UNKNOWN","sponsor":"Oystershell NV","startDate":"2024-03","conditions":["Onychomycosis"],"enrollment":132,"completionDate":"2025-09"},{"nctId":"NCT02812043","phase":"PHASE4","title":"Comparison Between Long-pulsed Nd:YAG, Amorolfine and Combination Treatment in Treating Non-dermatophyte Onychomycosis","status":"COMPLETED","sponsor":"Mahidol University","startDate":"2016-08","conditions":["Non-dermatophyte Onychomycosis"],"enrollment":60,"completionDate":"2019-12"},{"nctId":"NCT02679911","phase":"PHASE4","title":"Treatment of Onychomycosis With Loceryl (Amorolfine) Nail Lacquer 5% Versus Ciclopirox Nail Lacquer","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2015-09","conditions":["Foot Dermatoses"],"enrollment":20,"completionDate":"2016-06"},{"nctId":"NCT02705664","phase":"PHASE4","title":"Treatment of Onychomycosis With Loceryl (Amorolfine) Nail Lacquer 5% Versus a Two-course Treatment With Urea 40% Ointment and Bifonazole Cream 1%","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2016-01","conditions":["Foot Dermatoses"],"enrollment":22,"completionDate":"2016-09"},{"nctId":"NCT00938925","phase":"NA","title":"Effectiveness of Podiatry Care on Onychomycosis (EPOCAON)","status":"WITHDRAWN","sponsor":"University of Malaga","startDate":"2009-10","conditions":["Onychomycosis"],"enrollment":0,"completionDate":"2017-03"},{"nctId":"NCT02549001","phase":"PHASE3","title":"Study to Evaluate the Efficacy and Safety of P-3058 10% Nail Solution in the Treatment of Toenail Onychomycosis","status":"COMPLETED","sponsor":"Polichem S.A.","startDate":"2015-08-20","conditions":["Onychomycosis"],"enrollment":953,"completionDate":"2018-09-17"},{"nctId":"NCT03098342","phase":"NA","title":"Comparison of Efficacy and Safety Between Methylene Blue-mediated Photodynamic Therapy and 5% Amorolfine Nail Lacquer for Toenail Onychomycosis Treatment","status":"UNKNOWN","sponsor":"Chulalongkorn University","startDate":"2017-06-01","conditions":["Onychomycosis of Toenail"],"enrollment":42,"completionDate":"2019-01-31"},{"nctId":"NCT01851590","phase":"PHASE4","title":"Resin vs. Amorolfine vs. Terbinafine Treatment in Onychomycosis","status":"COMPLETED","sponsor":"Helsinki University Central Hospital","startDate":"2013-10","conditions":["Onychomycosis"],"enrollment":129,"completionDate":"2014-10"},{"nctId":"NCT01929187","phase":"NA","title":"A Randomized Study to Evaluate the Efficacy of Herbal Ingredients Combined With a Carrier System (Phytonail) Compared With Amorolfine 5% Nail Lacquer (Loceryl) in the Treatment of Toenail Onychomycosis","status":"UNKNOWN","sponsor":"National Taiwan University Hospital","startDate":"2013-02","conditions":["Onycomycosis"],"enrollment":72,"completionDate":"2014-07"},{"nctId":"NCT01528813","phase":"PHASE2","title":"Erbium-doped Yttrium Aluminium Garnet Laser(Er:Yag)Associated With Amorolfine Lacquer in the Treatment of Onychomycosis","status":"UNKNOWN","sponsor":"Brasilia University Hospital","startDate":"2012-02","conditions":["Onychomycosis"],"enrollment":30,"completionDate":"2013-12"},{"nctId":"NCT00459537","phase":"PHASE3","title":"Efficacy, Safety and Tolerability of Topical 10% Terbinafine Hydrogen Chloride Versus 5% Amorolfine Nail Lacquer in Patients With Mild to Moderate Toenail Onychomycosis","status":"COMPLETED","sponsor":"Novartis","startDate":"2007-03","conditions":["Onychomycosis"],"enrollment":1029,"completionDate":"2009-01"},{"nctId":"NCT01014637","phase":"PHASE4","title":"Efficacy, Safety and Cost-effectiveness of a Sequential Therapy With RV4104A Ointment, Ciclopiroxolamine Cream and Ciclopirox Film-forming Solution Compared With Amorolfine Nail Lacquer in Dermatophytic Onychomycosis","status":"UNKNOWN","sponsor":"Pierre Fabre Dermo Cosmetique","startDate":"2009-08","conditions":["Onychomycosis"],"enrollment":260,"completionDate":"2011-09"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NDDF":"003929","UNII":"AB0BHP2FH0","CHEBI":"CHEBI:599440","INN_ID":"5855","RXNORM":"17804","UMLSCUI":"C0051736","ChEMBL_ID":"CHEMBL489411","KEGG_DRUG":"D01720","DRUGBANK_ID":"DB09056","PUBCHEM_CID":"54260","SNOMEDCT_US":"332998007","SECONDARY_CAS_RN":"78613-38-4","MESH_SUPPLEMENTAL_RECORD_UI":"C038974"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":306,"therapeuticAreas":["Infectious Disease"],"atcClassification":{"source":"DrugCentral","atcCode":"D01AE16","allCodes":["D01AE16"]},"biosimilarFilings":[],"recentPublications":[{"date":"2026 Jan 1","pmid":"41534357","title":"Hexaconazole promotes deoxynivalenol synthesis by interfering with farnesyl pyrophosphate metabolism in Fusarium graminearum.","journal":"Ecotoxicology and environmental safety"},{"date":"2026 Jan 1","pmid":"41517574","title":"Fingernail Onychomycosis: A Laboratory-Based Retrospective Study with Species Profiling and Antifungal Susceptibility of Yeasts.","journal":"Journal of clinical medicine"},{"date":"2025 Nov","pmid":"41250813","title":"The First Isolation of Multiple Antifungal-Drug-Resistant Trichophyton Rubrum in China and the Novel Resistance Mechanism.","journal":"Mycoses"},{"date":"2025 Dec","pmid":"40936384","title":"Amorolfine hydrochloride cream and 2% crisaborole ointment: a study on their therapeutic benefits for keratotic tinea pedis.","journal":"The Journal of dermatological treatment"},{"date":"2025 Sep 2","pmid":"40838978","title":"In vitro susceptibility profile of Brazilian Sporothrix brasiliensis isolates to amorolfine hydrochloride and itraconazole.","journal":"Medical mycology"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Loceryl is a topical antifungal treatment used to study onychomycosis, nail diseases, and foot dermatoses in clinical trials.","enrichmentLevel":5,"visitCount":0,"trialStats":{"total":1,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T08:40:54.605679+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":false,"safety":true,"trials":true,"score":3}}